AVTX
AVTX
NASDAQ · Biotechnology

Avalo Therapeutics Inc

$16.60
+1.67 (+11.19%)
As of Apr 1, 2:16 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +98.3% upside
Low Target $27.78
Average Target $32.91
High Target $47.11
Current Price $16.60
Current
$16.60
Target
$32.91
$27.78 $32.91 avg $47.11
Scenario Analysis
Bear Case
$27.78
67.3%
Low target
Base Case
$32.91
+98.3%
Avg target
Bull Case
$47.11
+183.8%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$36.58
-54.6% from high
52-Week Low
$16.46
+0.9% from low
Target vs 52W High
$32.91
-10.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%